Named Patient Program for Olverembatinib (HQP1351)

Inclusion Criteria: • Patients who are suitable to receive Olverembatinib and for whom there is reasonable expectation that Olverembatinib may provide clinical benefit based on the medical judgment of their prescribing physician. Exclusion Criteria: * Existing risks of serious Arterial occlusive events (AOE), including myocardial infarction, stroke, stenosis of large arterial vessels of the brain, severe peripheral vascular disease, and recent revascularization procedures * Existing risks of serious Venous thromboembolic events (VTEs), including deep venous thrombosis, pulmonary embolism, and retinal vein thrombosis * Existing serious heart conditions, including acute/chronic heart failure, coronary artery disease * Existing conditions of severe liver malfunction * Existing conditions of severe myelosuppression * Existing conditions of severe hemorrhage * Pregnant or baby feeding